CorFlow Therapeutics AG
PrivateLast Round
Series B
Sep 9, 2024
Total Funding Raised
$58.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CorFlow Therapeutics AG is a medical technology company that develops diagnostic and therapeutic devices for the treatment of microvascular obstruction in heart attack patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CorFlow Therapeutics AG Comparables
Compare CorFlow Therapeutics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Abbott Laboratories | 71% | |
| Medtronic | 71% | |
| Bracco S.p.A. | 67% |
CorFlow Therapeutics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 9, 2024 | ||||
| Seed | Sep 12, 2018 |
Key People
Founding team and executive leadership
CorFlow Therapeutics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KOFA Healthcare | Series B |
| 415 Capital | Series B |
| Unorthodox Ventures | Series B |
| Panakès Partners | Series B |
| Wellington Partners | Series B |
| M&L Healthcare | Series B |
| M&L Healthcare Investments | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 273% MoM, reaching 2.2K.
- Apr 1, 2026
Second generation CoFI system now in clinical trials.
CorFlow Therapeutics AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CorFlow Therapeutics AG's valuation, stock price, and market status.
Is Corflow a public or private company?
Corflow is a private company.
What is the current stock price of Corflow?
Corflow is a private company with no public stock price. No recent secondary market data is available.
How much is Corflow worth (valuation)?
Valuation information for Corflow is not publicly available.
Can I buy Corflow stock?
Corflow shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Corflow's last funding round?
Corflow's most recent funding round was Series B on September 10, 2024.
Who are the main investors in Corflow?
Key investors in Corflow include Panakès Partners, Broadview Ventures.
Will Corflow IPO soon?
No public IPO plans have been announced for Corflow.
How can I track Corflow secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Corflow's secondary market activity and sign up for updates.